Clinical trials recruiting for Lung Cancer, Nonsmall Cell

Phase breakdown

Drugs and treatments being studied

Where trials are recruiting (top US states)

Top cities

Self-screener

Recruiting trials

• A Multicenter Cancer Biospecimen Collection Study
  NCT04510129 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• A Randomised Open-label Phase III Trial of REduced Frequency Pembrolizumab immuNothErapy for First-line Treatment of Patients With Advanced Non-small Cell Lung Cancer (NSCLC)
  NCT05085028 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 37 locations
• Efficacy Analysis of Neoadjuvant Treatment in Lung Cancer Using Low-dose Nivolumab Combined With Chemotherapy
  NCT06667154 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• I3LUNG: Integrative Science, Intelligent Data Platform for Individualized LUNG Cancer Care With Immunotherapy
  NCT05537922 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 4 locations
• Immunonutrition for Improving the Efficacy of Immunotherapy in Patients With Metastatic Non-small Cell Lung Cancer
  NCT05384873 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Prospective Data Collection Initiative on Thoracic Malignancies
  NCT06996249 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 23 locations
• Study of PRO in Patients With Advanced Pancreatic or Biliary Tract Cancer (BetterEveryDay)
  NCT04611867 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Tocilizumab and Atezolizumab in Adults With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Refractory to 1st Line Immune Checkpoint Inhibitor-Based Therapy
  NCT04691817 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• ctDNA-MRD Guided Consolidation Toripalimab in Stage IB-IIIA NSCLC
  NCT06426511 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location

Related conditions

Trials recruiting for Lung Cancer, Nonsmall Cell often also study these conditions. Each links to its own recruiting-trial list.

Common questions

Are these trials free to join?

Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.

How do I know if I am eligible for Lung Cancer, Nonsmall Cell trials?

Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.

Is this list complete?

No. For the full list, search ClinicalTrials.gov.